Rafael Holdings, Inc. RFL
NYSE · XNYS · stock · Pharmaceutical Preparations · website · IPO 2018-03-12
Chart by TradingView
2/9
Piotroski F — financial health
0.8
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Revenue | $30,000 | $637,000 | $279,000 | $410,000 | $802,000 |
| Operating income | -$29.2M | -$102.6M | -$15.0M | -$60.5M | -$28.2M |
| Net income | -$30.5M | -$34.4M | -$1.9M | -$124.7M | -$23.1M |
| Operating cash flow | -$18.9M | -$7.8M | -$10.9M | -$26.0M | -$15.3M |
| Free cash flow | -$18.9M | -$7.9M | — | -$26.0M | -$15.5M |
| Total assets | $114.1M | $96.8M | $98.8M | $118.3M | $154.1M |
| Total liabilities | $15.7M | $10.6M | $2.2M | $21.1M | $17.4M |
| Shareholders' equity | $98.4M | $86.3M | $96.6M | $97.2M | $136.7M |
| Ratios | |||||
| Operating margin | -97196.7% | -16111.0% | -5391.8% | -14750.5% | -3516.1% |
| Net margin | -101733.3% | -5401.9% | -672.4% | -30404.4% | -2875.4% |
| FCF margin | -63093.3% | -1247.3% | — | -6351.2% | -1935.2% |
| Return on assets | -26.7% | -35.5% | -1.9% | -105.4% | -15.0% |
| Return on equity | -31.0% | -39.9% | -1.9% | -128.2% | -16.9% |
| Current ratio | 4.89 | 9.65 | 38.67 | 5.15 | 0.85 |
| Revenue growth | -95.3% | 128.3% | -32.0% | -48.9% | -83.7% |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 89,138 | $111,423 |
Why these scores methodology →
Piotroski F-score: 2/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 0.8 (distress)
- Working capital / assets 0.395
- Retained earnings / assets -2.035
- EBIT / assets -0.256
- Equity / liabilities 6.251
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001713863 · as of 2025-07-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.